Skip to main content
OpenTrials
Completed

NCT Number: NCT07067996

Erector Spinae Plane Block for Analgesia During ESWL

this study aims to compare between efficacy of erector spinae plane block and conventional multimodal analgesia in Extracorporeal shock wave lithotripsy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Stone Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Nephrolithiasis Urogenital Diseases Urolithiasis Urologic Diseases

Age range

21 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sohag University Hospital

Sohag, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult Patients undergoing ESWL with 2-3 cm renal stones
  • patients between the ages of 21 and 60,
  • both sexes,
  • BMI ≥18≤30 kg/m²
  • Able to give informed consent.
  • Patients older than 18 years with American Society of Anesthesiologists Physical Status I or II and

Exclusion criteria

  • Coagulopathy or on anticoagulants
  • Infection at the ESPB injection site
  • BMI ≥30 kg/m²
  • Patient refusal.
  • patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
  • patients with a history of allergies to any study drugs

Treatment and study plan

Erector Spinae Plane Block

Procedure

erector spinae plane block will be given as intraoperive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

Nalbuphine

Drug

Nalbuphine will be given as intraopertive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

Primary outcomes

  1. This study aims to evaluate the efficacy of Erector Spinae Plane Block analgesia for patients undergoing ESWL &compare between it and conventional multimodal Analgesia .

    Time frame: 6 hours postopertive

    postoperative pain by visual analog score from 0 to 10 (where 0 indicates no pain and 10 the worst possible pain

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 16, 2025
Registry last updated
Jul 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.